Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab for Prophylaxis of Acute Rejection in Renal Transplantation
NCT00565331Phase 3Completed
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2007
- Primary completion
- Dec 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in graft rejection, sponsored by Radboud University Medical Center. Started Dec 2007; status: completed.
02
Drugs
rituximab
03
Conditions
graft rejection
Beyond the preview
Go deeper on NCT00565331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00565331.